SectorPharmaceutical
Established Date--
Listing Date21/03/2014
ExchangeNASDAQ Stock Exchange
Full-time Employees2
Fiscal Year Ends31/12
Security TypeCommon stock
Office address945 Concord Street, Suite 1217, Framingham, MA 01701
Business
IntroductionPulmatrix, Inc., was incorporated as a Delaware corporation in 2013. The Company is a biopharmaceutical company focused on developing inhaled therapeutic products for central nervous system diseases and respiratory diseases using its patented iSPERSE dry powder delivery technology.
